Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Keyrus Biopharma | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Multicenter prospective observational study, involving all adult patients who underwent cardiac surgery with extracorporeal circulation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The international recommendations published by ESA in 2016 | Review the concordance between the presence / absence of indication (according to the international recommendations published by ESA in 2016) and the prescription / non-prescription of fibrinogen concentrates | 13 Months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Adult patient that underwent a cardiac surgery with extracorporeal circulation.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Longrois Dan, Pr | Contact | dan.longrois@aphp.fr |
Not provided
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41286643 | Derived | Longrois D, Albaladejo P, Bedague D, Ouattara A, Bougle A, Dureau P, Cholley B, Mertes PM, Provenchere S, Robin E, Besch G, Grelet T, Grosjean S, Guinot PG, Rozec B, Rigal JC, Fellahi JL, Colson P; SFAR Research Committee. Compliance with ESAIC guidelines for fibrinogen concentrate prescription in cardiac surgery: a multicentre French cohort study. BMC Anesthesiol. 2025 Nov 24;25(1):594. doi: 10.1186/s12871-025-03347-w. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided